Financials Genertec Universal Medical Group Company Limited

Equities

2666

HK0000255361

Corporate Financial Services

Delayed Hong Kong S.E. 02:59:41 2024-04-29 am EDT 5-day change 1st Jan Change
4.72 HKD +0.64% Intraday chart for Genertec Universal Medical Group Company Limited +0.85% +5.12%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 9,049 8,364 8,677 7,919 7,719 8,212 - -
Enterprise Value (EV) 1 43,125 8,364 8,677 7,919 7,719 8,212 8,212 8,212
P/E ratio 6.06 x 5.08 x 5.04 x 4.5 x 4.12 x 4.28 x 3.61 x 3.98 x
Yield 5.01% 5.36% 6.38% 7.12% - 8.19% 8.8% 8.29%
Capitalization / Revenue 1.33 x 0.98 x 0.88 x 0.66 x 0.57 x 0.54 x 0.48 x 0.46 x
EV / Revenue 1.33 x 0.98 x 0.88 x 0.66 x 0.57 x 0.54 x 0.48 x 0.46 x
EV / EBITDA 3.66 x 2.96 x 2.89 x 2.42 x 2.27 x 2.33 x 2.24 x 2.19 x
EV / FCF -4.45 x -6.09 x -4.86 x 5.46 x - 2.62 x 2.88 x 2.39 x
FCF Yield -22.5% -16.4% -20.6% 18.3% - 38.2% 34.8% 41.9%
Price to Book 0.81 x 0.67 x 0.59 x 0.51 x - 0.53 x 0.46 x 0.45 x
Nbr of stocks (in thousands) 1,716,305 1,716,305 1,891,540 1,891,540 1,891,540 1,891,540 - -
Reference price 2 5.273 4.873 4.587 4.186 4.081 4.341 4.341 4.341
Announcement Date 3/24/20 3/31/21 3/29/22 3/29/23 3/27/24 - - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 6,816 8,521 9,914 11,912 13,650 15,313 17,184 17,971
EBITDA 1 2,473 2,830 2,998 3,271 3,408 3,517 3,658 3,746
EBIT 1 2,333 2,560 2,679 2,833 2,899 3,007 3,127 3,193
Operating Margin 34.23% 30.04% 27.02% 23.78% 21.24% 19.64% 18.2% 17.77%
Earnings before Tax (EBT) 1 2,212 2,365 2,692 2,704 2,866 3,247 3,486 3,181
Net income 1 1,489 1,648 1,835 1,890 2,021 2,112 2,414 2,279
Net margin 21.84% 19.33% 18.51% 15.87% 14.81% 13.79% 14.05% 12.68%
EPS 2 0.8700 0.9600 0.9100 0.9300 0.9900 1.014 1.202 1.090
Free Cash Flow 1 -2,032 -1,373 -1,786 1,449 - 3,134 2,856 3,443
FCF margin -29.82% -16.11% -18.01% 12.16% - 20.47% 16.62% 19.16%
FCF Conversion (EBITDA) - - - 44.3% - 89.11% 78.08% 91.91%
FCF Conversion (Net income) - - - 76.67% - 148.4% 118.3% 151.08%
Dividend per Share 2 0.2641 0.2613 0.2926 0.2982 - 0.3556 0.3822 0.3600
Announcement Date 3/24/20 3/31/21 3/29/22 3/29/23 3/27/24 - - -
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 34,076 - - - - - - -
Net Cash position - - - - - - - -
Leverage (Debt/EBITDA) 13.78 x - - - - - - -
Free Cash Flow 1 -2,032 -1,373 -1,786 1,449 - 3,134 2,856 3,443
ROE (net income / shareholders' equity) 14.1% 14.8% 15.4% 14% - 13.1% 13% 11.7%
ROA (Net income/ Total Assets) 2.83% 2.93% 3.09% 2.84% - 2.7% 2.66% 2.59%
Assets 1 52,555 56,280 59,393 66,550 - 78,215 90,758 87,992
Book Value Per Share 2 6.490 7.240 7.810 8.260 - 8.240 9.430 9.750
Cash Flow per Share -1.060 - - - - - - -
Capex 1 194 401 385 608 - 799 834 897
Capex / Sales 2.85% 4.7% 3.88% 5.1% - 5.21% 4.85% 4.99%
Announcement Date 3/24/20 3/31/21 3/29/22 3/29/23 3/27/24 - - -
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
4.341 CNY
Average target price
5.752 CNY
Spread / Average Target
+32.48%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 2666 Stock
  4. Financials Genertec Universal Medical Group Company Limited